“Venous Leg Ulcer: Pathophysiology and Treatment Highlights”
Event Navigation
Milliken* and Pfiedler Education presents…“Venous Leg Ulcer: Pathophysiology and Treatment Highlights”
Venous leg ulcers (VLUs) are the most common cause of lower extremity ulceration and are challenging for both patients and clinicians to manage, often requiring a minimum of 12 weeks to heal. Additionally, VLUs have high rates of recurrence. To promote a healing environment for VLUs, treatment is targeted at reducing edema, managing moisture, and preventing infection. Compression therapy has long been the standard of care for VLUs, but patient adherence to the treatment regimen may be hindered by physical limitations, pain, and application difficulty. Advanced treatment strategies for the management of VLUs maintain an optimal environment for wound healing along with compression therapy to reduce pain, facilitate healing, and prevent recurrence. The goal of this program is to educate a broader audience on advanced treatment strategies for patients with venous leg ulcers.
Learning Objectives | At the end of this session, participants should be able to:
- Review etiology and patient risk factors for the development of VLUs.
- Discuss challenges associated with traditional treatment and management of VLUs.
- Describe advanced treatment strategies for patients with VLUs to promote healing and improve their quality of life.
Presenter:
Lucian G. Vlad, M.D. | Wound Care Physician | Plastic & Reconstructive Surgery Department | Wake Forest School of Medicine
Target Audience: Nurses, primary care providers, podiatrists
Continuing Education: Complimentary Online Webinar. 1 Contact Hour for nurses, primary care providers, podiatrists. California Board of Registered Nursing. Association of PeriOperative Registered Nurses is provider-approved by the California Board of Registered Nursing, Provider Number CEP 13019 for 1.0 contact hour.
Funding provided by Milliken*
Questions? Email: Pfiedler Webinars <webinars@pfiedler.com>
* NOTE: This is a supplier and/or industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.
